Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial

HAEMATOLOGICA(2023)

引用 0|浏览37
暂无评分
摘要
Not available.
更多
查看译文
关键词
oral azacitidine maintenance,acute myeloid leukemia,initial chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要